U.S. Markets open in 16 hrs, 27 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,310.99 | -76.62 | -0.82% |
| NASDAQ | 1,779.01 | -65.24 | -3.54% |
| S&P 500 | 998.01 | -5.34 | -0.53% |
| Day Low | 0.005 | |
|---|---|---|
| Day High 11:55 AM EDT | 0.01 |
|
| Range | 0.01 | |
| Volume | 101,427 | |
| 30-Day Avg. Vol. | 466,000 |
|
| Difference | -78.23% | |
| Market Cap. | 214,920 | |
| Change | 0 | |
| Shares Out. | — | |
| Percent Traded | 0.24% | |
| Revenue (LFY) | 0 | |
| Earnings (TTM) | -65.64 M | |
| Next Earnings | 11/14/2008 |
|
| EPS (TTM) | -2.46 |
| 52-Wk Low | 0.005 | |
|---|---|---|
| 52-Wk High 11/29/07 | 4.93 |
|
| Range | 4.92 | |
| Prev. Close 10/13/08 | 0.005 | |
| Today's Open | 0.005 | |
| Change | 0.00% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 2.1278 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Genitope is a drug development company in arrested development. It had hoped to find new ways to fight cancer with old weapons, but now it is just hoping to find a future. The company was researching immunotherapy ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | — — | — — |
—
—
|
| Last Quarter | — — | — — |
—
—
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | — | -7.68 M |
| Operating Income | -13.51 M | -62.33 M |
| Net Income | -53.68 M | -65.65 M |
